Pathological extension of prostate cancer as defined by gleason score on biopsy by Dall'Oglio, Marcos Francisco et al.
326
EXTENSION OF PROSTATE CA BY GLEASON SCORE ON BIOPSYClinical Urology
International Braz J Urol
Official Journal of the Brazilian Society of Urology
Vol. 31 (4): 326-330, July - August, 2005
PATHOLOGICAL EXTENSION OF PROSTATE CANCER AS DEFINED BY
GLEASON SCORE ON BIOPSY
MARCOS F. DALL’OGLIO, ALEXANDRE CRIPPA, MARIO PARANHOS, LUCIANO J.
NESRALLAH, KATIA R. LEITE, MIGUEL SROUGI
Division of Urology, Paulista School of Medicine, Federal University of Sao Paulo, UNIFESP, Sao Paulo,
SP, Brazil
ABSTRACT
Introduction: Based on the importance of the Gleason score on the behavior of prostate
adenocarcinoma, this study attempts to predict the extension of prostate adenocarcinoma pre-opera-
tively, as defined by the Gleason score on biopsy, in individuals who will undergo radical prostatec-
tomy.
Materials and Methods: We selected 899 individuals who underwent retropubic radical pros-
tatectomy from 1988 to 2004. Clinical and pathological data obtained in the preoperative period were
retrospectively analyzed through digital rectal examinations of the prostate, initial serum PSA levels
and pathological data provided by biopsy. The Gleason score on biopsy was assessed and divided into
3 groups: 2 to 6, 7, and 8 to 10, and correlated with the possibility of the disease being confined to the
prostate.
Results: From the 899 selected patients, 654 (74%) showed Gleason scores of 2 to 6, 165
(18%) had a score of 7 and 80 (9%) had scores of 8 to 10 on biopsy. The likelihood of confined
diseases, extraprostatic extensions, invasion of seminal vesicles and lymph nodal involvement were
respectively: 74%, 18%, 8% and 0.8% for a Gleason score of 2 to 6, 47%, 30%, 19% and 4% for a
Gleason score of 7, and 49%, 29%, 18% and 4% for a Gleason score of 8 to 10.
Conclusion: In patients who will undergo radical prostatectomy due to prostate adenocarci-
noma, a Gleason score of 7 on biopsy shows the same behavior as a Gleason score of 8 to 10 in
relation to extension of disease.
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INTRODUCTION
The risk for progression of prostate cancer
following radical prostatectomy (RP) is predicted by
Gleason score, and pathological and surgical margins
(1). The histological grade is regarded as a highly rel-
evant prognostic factor (2,3), and in tumors with high
Gleason score, the disease is often associated with ag-
gressive biological behavior and risk of occult disease
(4,5). Attempting to determine the extension of the dis-
ease preoperatively is fundamental, since even tumors
with a high Gleason score, but in a confined disease,
present a disease-free outcome in 60% to 71% of cases
(6). It is known that the recurrence of prostate cancer
is higher in individuals with Gleason scores of 8 to 10
than with a score of 7, as defined by the surgical speci-
men. In such cases, the disease is confined in 43.1%
and 9.2% for Gleason 7 and 8-10 respectively (7).
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Preoperative prediction of the extension of
the disease, which is determined by simply discrimi-
nating the Gleason score in the histopathology of bi-
opsy fragments, will allow us to anticipate the possi-
bility of extraprostatic disease in patients who will
undergo RP.
Since there are no accurate data establishing
if the Gleason score on biopsy could predict the loca-
tion of prostate cancer (confined versus
extraprostatic), this study aimed to compare prostate
tumors with Gleason scores of 2 to 6, 7 and 8 to 10 as
defined by biopsy, and to verify the presence of
extraprostatic disease following radical prostatectomy
through the pathological parameters of the surgical
specimen.
MATERIALS AND METHODS
We retrospectively studied 961 patients un-
dergoing retropubic radical prostatectomy with bilat-
eral selective iliac lymphadenectomy due to prostate
adenocarcinoma, in the period from September 1988
to December 2002. The patient age range was from
40 to 83 years, with a mean age of 62.9 ± 7.4 years.
The study included patients whose medical
records indicated the total number of fragments re-
moved on biopsy, the number of fragments with can-
cer, Gleason score, PSA and pathological study of
the surgical specimen. Fifty-four patients who re-
ceived neoadjuvant treatment were excluded, as were
another 8 who were diagnosed through endoscopic
resection of the prostate or transvesical prostatectomy,
thus totaling 899 patients. The mean PSA was 10.1 ±
7.7 ng/mL (ranging from 0.3 to 72 ng/mL). In rela-
tion to clinical stage, 432 (48%) patients were classi-
fied as T1c, 219 (24%) as T2a, 173 (19.3%) as T2b,
68 (7.6%) as T2c and 7 (0.8%) as T3a. The mean
percentage of affected fragments was 41% ± 24%
(ranging from 5% to 100%). The mean Gleason score
on biopsy was 5.8 ± 1.3.
Pathological Assessment
All surgical specimens, consisting of pros-
tate, seminal vesicles and obturator lymph nodes, were
assessed by the same pathologist. Specimens were
fixed in 10% formalin for 6 hours in average and un-
derwent a routine of measuring and weighing the
gland on a digital balance with 2 decimal places of
precision. Thin transversal sections were performed
in the surgical margins relative to the bladder neck
and the prostate apex. Using the urethra as a refer-
ence, the remaining gland had its margins stained with
India ink, and was then sequentially sliced each 0.3
millimeters. Eight to 10 sections from each lobe were
included for histological study. Seminal vesicles were
sectioned at their base, and longitudinal sections were
subsequently made for histological examination.
Obturator lymph nodes were dissected and sliced for
inclusion in the study.
The material underwent the usual processing
in preparation for microscopic examination, with de-
hydration in alcohol, clearing in xylol and embed-
ding in paraffin. Fragments were stained with hema-
toxylin and eosin and then analyzed under a binocu-
lar light microscope. The assessed parameters were:
Histological grade and Gleason score – The
Gleason histological classification was used for as-
sessing tumor differentiation, considering exclusively
the acinar pattern.
Surgical margins – Positive margins were
defined as the presence of a tumor in the surgical
transection margins, as defined by the presence of
India ink.
Infiltration of periprostatic tissue – Invasion
of fat tissue and periprostatic neurovascular plexus
was considered as non-confined disease.
Infiltration of seminal vesicles – Involvement
of seminal vesicles was considered only when the
tumor invaded their parenchyma, and not the adven-
titial area.
Lymph nodal metastases – Obturator lymph
nodes containing tumor are considered as positive
metastases.
Statistical analysis was performed with the
qui-square test with values of p < 0.05 being defined
as significant.
RESULTS
Table-1 summarizes the pathological data for
the Gleason score on biopsy and the location of pros-
tate adenocarcinoma. Of the 899 selected patients,
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we observed that 654 (73%) had a Gleason score of 2
to 6. Another 165 (18%) presented a Gleason score
of 7, and 80 (9%) had a Gleason score of 8 to 10, as
identified by biopsy. Among the patients with a
Gleason score of 7, 78 (47%) had organ-confined lo-
cation, 50 (30%) presented extraprostatic invasion,
31 (19%) had involvement of seminal vesicle and 6
(4%) showed lymph nodal involvement. Those tumors
with a Gleason score of 8 to 10 presented prostate-
confined disease in 39 (49%) of patients, 23 of them
(29%) had extraprostatic disease and 3 (3%) showed
lymph nodes affected by the disease.
There was a significant difference only when
comparing Gleason scores of 2 to 6 with a 7 or an 8
to 10, with no significant difference observed between
the latter 2 groups.
COMMENTS
Our study showed that in individuals under-
going prostate biopsy, the presence of Gleason pat-
tern 4 or 5 determines a risk of 51 to 53% for
extraprostatic disease in the surgical specimen.
Merely dividing the Gleason score into ranges
of 2 to 6 and 7 to 10 seems reasonable for predicting
the extension of disease, since in univariate analysis
the behavior of a Gleason score 7 was statistically
identical to the behavior of patients with Gleason
scores of 8 to 10. In our opinion, the similarity in
findings of extraprostatic disease between 7 and 8 to
10 can be explained by the presence of a pattern of 4
or 5 (8), which is invariably present. Patients with up
to 10% of pattern 4 or 5 in the surgical specimen have
more than a 70% probability of becoming disease-
free, while individuals with more than 50% of pat-
tern 4 or 5 present progressive disease in 82% of cases
(9).
The percentage of positive fragments on bi-
opsy correlates to tumor volume. Additionally, the
presence of a 4 or 5 pattern in the surgical specimen
also determines a worse prognosis concerning out-
come (10), however, as we have demonstrated, the
chance of identifying confined disease is the same
for 7 and for 8 to 10. Moreover, we could observe
that patients with a Gleason score lower than 7 present
a recurrence of the disease in 13% of cases, and this
rate approaches 60% with a Gleason score between 7
and 10 (11). In our sample, we showed that 49% of
individuals with a Gleason score between 8 and 10
had confined disease, 19% had neoplastic involve-
ment of the seminal vesicles, and in only 8% of pa-
tients with a score lower than or equal to 6 were the
seminal vesicles affected by the tumor. There is some
controversy as whether a Gleason score of 7 has a
different outcome from a score of 8 to 10 in relation
to confined disease and recurrence (5). As we know,
the Gleason score is composed of the 2 volumetri-
cally prevalent patterns in the specimen, thus a
Gleason score of 7 can be 3 + 4 or 4 + 3. Since the
percentage of pattern 4 influences whether the dis-
ease is confined or not (10), studies comparing
Gleason scores of 7, 4 + 3 and 3 + 4 have been pub-
lished. Chan et al. (12) observed 34.7% of confined
disease in patients undergoing radical prostatectomy
with a Gleason score of 7 in the surgical specimen.
However, the risk of progression was 20% higher with
scores of 4 + 3 than in the 3 + 4 group after a 10-year
follow-up. However, in order to obtain the results,
many of these studies derived from the surgical speci-
men and not from the biopsy (5), which may not be
Table 1 –  Gleason score on biopsy and location of prostate cancer in the surgical specimen.
Gleason Score
on Biopsy
2 to 6
7
8 to 10
Total
Patients
654   (73%)
165   (18%)
  80     (9%)
899 (100%)
   Organ-confined
 484 (74%)
  78 (47%)
  39 (49%)
 601 (67%)
 Extraprostatic
118 (18%)
 50 (30%)
 23 (29%)
191 (21%)
Positive Seminal
Vesicle
        50   (8%)
31 (19%)
15 (19%)
96 (11%)
Positive Lymph
 Nodes
      2 (< 1 %)
           6      (4%)
           3      (3%)
         11      (1%)
2 to 6 vs. 7 or 8 to 10 (p < 0.05); 7 vs. 8 to 10 (p > 0.05)
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equal if we calculate the difference between Gleason
scores of 3 + 4 and 4 + 3 from the biopsy fragments.
A study conducted by Grober et al. (13) demonstrated
that there was no difference between the 2 groups (3
+ 4 and 4 + 3) of Gleason score 7 on biopsy in terms
of the disease being confined or not, having
extraprostatic extension or showing involvement of
the seminal vesicles, which agrees with our data. In
fact, a score 7 on biopsy should take into account not
only the first score pattern, but PSA levels and the
number of positive fragments on biopsy as well (14);
if we have 4 + 3 with 2 or less fragments affected by
tumor in 68.7% of patients, the disease will be con-
fined. On the other hand, if the score is 3 + 4 with
more than 2 affected fragments, this number will drop
to 41.1%. These data have been confirmed by Peller
et al. (15) who, when comparing patients with Gleason
scores of 7 and 100% positive fragments on biopsy
with a Gleason score of 8 and the same number of
positive fragments, were able to show agreement in
97% of cases for predicting confined disease.
When comparing our results with Tefilli et
al. (7), we verified that when the Gleason score is
between 2 and 6, 74% of the patients have confined
disease versus 69% with non-confined disease. On
the other hand, with a score of 7, we see 47% versus
43%; that is, quite similar values. However, when
comparing patients with a Gleason score between 8
and 10, we found 48.8% of patients with confined
disease versus only 9.2% with non-confined disease.
This difference can be explained by the fact that the
mean PSA in patients with a score of 7 was 12 ng/mL
versus 25 ng/mL in patients with a Gleason score
between 8 to 10 (7). Epstein et al. (1) found a rate of
confined disease of 30% in men with a Gleason score
of 7, and, of them, approximately 70% were disease-
free after 10 years.
In relation to a Gleason score ≥ 8, we found
9.5% to 31% of patients with confined disease (7). It
is relevant that these patients had localized disease,
because 82% of these individuals are not likely to
have recurrent disease during a 5-year follow-up,
despite the high Gleason score (16). Egan & Bostwick
(17) demonstrated that individuals with a Gleason
score of 7 had confined disease in 48% of cases ver-
sus 53% in men with a Gleason score of 8. In our
study, we found 48.8% of confined disease with a
score between 8 and 10. As shown previously, there
is a wide variation in results when we attempt to use
isolated parameters for predicting confined disease,
and this is due to several factors that are involved in
prostate adenocarcinoma. Since the construction of
the first nomogram for predicting confined disease
using PSA, clinical stage and Gleason score, more
than one parameter is used in order to reduce the prob-
ability of error (3).
CONCLUSION
It is important to consider the presence of
Gleason grade 4 or 5 on prostate biopsy for planning
the management of prostate cancer. In these cases,
the disease is organ-confined in the pathological ex-
amination of the surgical specimen in only half the
cases.
Adriana Sanudo
performed the statistical analysis.
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